PAR 4.55% 23.0¢ paradigm biopharmaceuticals limited..

Nick, no doubt we need some patience if you look too closely at...

  1. 4,276 Posts.
    lightbulb Created with Sketch. 6784


    Nick, no doubt we need some patience if you look too closely at the SP!

    But to keep ME motivated to stay the course (let alone others) there is a lot on the horizon, not all of it is distant. We have some catalysts coming...

    Most of us know them, but a few highlights...somewhat in chronological order but of course subject to change...


    Evercore Bio Conference
    FDA Type C feedback
    R & D Day
    Manuscript (Twins) - Peer review
    JPM Morgan Conference

    Then we will have the big ones:

    IND - OA
    IND - MPS VI

    After that?
    SAS - Patient Pay Program?
    And of course in the background TGA Provisional Submission?
    Sometime maybe towards end of next year we will also have the P2 MPS I read out (Adelaide)

    More?
    Twins next stage (Could be a regional deal? Could be a P3 Design)
    Research Tie-up advancement

    Background?
    ..Yes and while all of the above is enough to keep me going...there always looms (and it gets larger as we cross the IND's and are in the midst of P3 trials), the real possibility of a distribution deal.

    I'm not longer bored. I also see the 'hike' you speak of coming one fine day, perhaps out of the blue.
    I look forward to the day Pool_COO summons AF and I to launch-pad...it will come one day.



    DYOR

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.0¢
Change
0.010(4.55%)
Mkt cap ! $80.45M
Open High Low Value Volume
22.8¢ 23.3¢ 22.5¢ $46.92K 203.9K

Buyers (Bids)

No. Vol. Price($)
1 337 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 138166 5
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.